GRB7 is required for triple-negative breast cancer cell invasion and survival

Orsolya Giricz, Verónica Calvo, Stephanie C. Pero, David N. Krag, Joseph A. Sparano, Paraic A. Kenny

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Triple-negative breast cancer (TNBC) is a heterogeneous disease that is usually associated with poor prognosis, and frequently associated with the basal-like breast cancer gene expression profile. There are no targeted therapeutic modalities for this disease, and no useful bio-markers. High GRB7 RNA expression levels are associated with an elevated risk of recurrence in patients with operable TNBC treated with standard adjuvant anthracycline and taxane therapy. To determine whether GRB7 is involved in the pathobiology of TNBC, we evaluated the biological effects of GRB7 inhibition in a panel of triple-negative cell lines=MDA-MB-468, MDA-MB-231, HCC70, and T4-2. We found GRB7 inhibition reduced cell motility and invasion of these cell lines and promoted cell death by apoptosis in 3D culture. These data suggest that GRB7 itself, or GRB7-dependent pathways, may prove to be important therapeutic targets in this disease.

Original languageEnglish (US)
Pages (from-to)607-615
Number of pages9
JournalBreast Cancer Research and Treatment
Volume133
Issue number2
DOIs
StatePublished - Jun 2012

Fingerprint

Triple Negative Breast Neoplasms
Cell Survival
Cell Line
Neoplasm Genes
Anthracyclines
Transcriptome
Cell Movement
Cell Death
Therapeutics
RNA
Apoptosis
Breast Neoplasms
Recurrence

Keywords

  • Adapter proteins
  • GRB7
  • Receptor tyrosine kinase signaling
  • Triple-negative breast cancer
  • Tumor cell invasion

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

GRB7 is required for triple-negative breast cancer cell invasion and survival. / Giricz, Orsolya; Calvo, Verónica; Pero, Stephanie C.; Krag, David N.; Sparano, Joseph A.; Kenny, Paraic A.

In: Breast Cancer Research and Treatment, Vol. 133, No. 2, 06.2012, p. 607-615.

Research output: Contribution to journalArticle

Giricz, Orsolya ; Calvo, Verónica ; Pero, Stephanie C. ; Krag, David N. ; Sparano, Joseph A. ; Kenny, Paraic A. / GRB7 is required for triple-negative breast cancer cell invasion and survival. In: Breast Cancer Research and Treatment. 2012 ; Vol. 133, No. 2. pp. 607-615.
@article{9943f9714d0f4e3f9087771089b22c85,
title = "GRB7 is required for triple-negative breast cancer cell invasion and survival",
abstract = "Triple-negative breast cancer (TNBC) is a heterogeneous disease that is usually associated with poor prognosis, and frequently associated with the basal-like breast cancer gene expression profile. There are no targeted therapeutic modalities for this disease, and no useful bio-markers. High GRB7 RNA expression levels are associated with an elevated risk of recurrence in patients with operable TNBC treated with standard adjuvant anthracycline and taxane therapy. To determine whether GRB7 is involved in the pathobiology of TNBC, we evaluated the biological effects of GRB7 inhibition in a panel of triple-negative cell lines=MDA-MB-468, MDA-MB-231, HCC70, and T4-2. We found GRB7 inhibition reduced cell motility and invasion of these cell lines and promoted cell death by apoptosis in 3D culture. These data suggest that GRB7 itself, or GRB7-dependent pathways, may prove to be important therapeutic targets in this disease.",
keywords = "Adapter proteins, GRB7, Receptor tyrosine kinase signaling, Triple-negative breast cancer, Tumor cell invasion",
author = "Orsolya Giricz and Ver{\'o}nica Calvo and Pero, {Stephanie C.} and Krag, {David N.} and Sparano, {Joseph A.} and Kenny, {Paraic A.}",
year = "2012",
month = "6",
doi = "10.1007/s10549-011-1822-6",
language = "English (US)",
volume = "133",
pages = "607--615",
journal = "Breast Cancer Research and Treatment",
issn = "0167-6806",
publisher = "Springer New York",
number = "2",

}

TY - JOUR

T1 - GRB7 is required for triple-negative breast cancer cell invasion and survival

AU - Giricz, Orsolya

AU - Calvo, Verónica

AU - Pero, Stephanie C.

AU - Krag, David N.

AU - Sparano, Joseph A.

AU - Kenny, Paraic A.

PY - 2012/6

Y1 - 2012/6

N2 - Triple-negative breast cancer (TNBC) is a heterogeneous disease that is usually associated with poor prognosis, and frequently associated with the basal-like breast cancer gene expression profile. There are no targeted therapeutic modalities for this disease, and no useful bio-markers. High GRB7 RNA expression levels are associated with an elevated risk of recurrence in patients with operable TNBC treated with standard adjuvant anthracycline and taxane therapy. To determine whether GRB7 is involved in the pathobiology of TNBC, we evaluated the biological effects of GRB7 inhibition in a panel of triple-negative cell lines=MDA-MB-468, MDA-MB-231, HCC70, and T4-2. We found GRB7 inhibition reduced cell motility and invasion of these cell lines and promoted cell death by apoptosis in 3D culture. These data suggest that GRB7 itself, or GRB7-dependent pathways, may prove to be important therapeutic targets in this disease.

AB - Triple-negative breast cancer (TNBC) is a heterogeneous disease that is usually associated with poor prognosis, and frequently associated with the basal-like breast cancer gene expression profile. There are no targeted therapeutic modalities for this disease, and no useful bio-markers. High GRB7 RNA expression levels are associated with an elevated risk of recurrence in patients with operable TNBC treated with standard adjuvant anthracycline and taxane therapy. To determine whether GRB7 is involved in the pathobiology of TNBC, we evaluated the biological effects of GRB7 inhibition in a panel of triple-negative cell lines=MDA-MB-468, MDA-MB-231, HCC70, and T4-2. We found GRB7 inhibition reduced cell motility and invasion of these cell lines and promoted cell death by apoptosis in 3D culture. These data suggest that GRB7 itself, or GRB7-dependent pathways, may prove to be important therapeutic targets in this disease.

KW - Adapter proteins

KW - GRB7

KW - Receptor tyrosine kinase signaling

KW - Triple-negative breast cancer

KW - Tumor cell invasion

UR - http://www.scopus.com/inward/record.url?scp=84863724949&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863724949&partnerID=8YFLogxK

U2 - 10.1007/s10549-011-1822-6

DO - 10.1007/s10549-011-1822-6

M3 - Article

C2 - 22005836

AN - SCOPUS:84863724949

VL - 133

SP - 607

EP - 615

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

SN - 0167-6806

IS - 2

ER -